A phase I trial of recombinant human interleukin-1β alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer Journal Article


Authors: Crown, J.; Jakubowski, A.; Kemeny, N.; Gordon, M.; Gasparetto, C.; Wong, G.; Sheridan, C.; Toner, G.; Meisenberg, B.; Botet, J.; Applewhite, J.; Sinha, S.; Moore, M.; Kelsen, D.; Buhles, W.; Gabrilove, J.
Article Title: A phase I trial of recombinant human interleukin-1β alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer
Abstract: We studied escalating doses of recombinant human interleukin-1β (IL-1β) alone and after a myelosuppressive dose of 5-fluorouracil (5-FU) in patients with gastrointestinal cancer. Transient neutropenia, monocytopenia, and lymphocytopenia were observed followed by a 1.3- to 6.0-fold (mean, 3.46-fold) dose-dependent neutrophil leukocytosis (P < .00001) on the days of IL-1β administration. Increases in platelet counts were observed at a median of 14 days (range, 6 to 23) after IL-1β administration. Transient hypoglycemia, rebound hyperglycemia, elevations in serum cortisol, and C-reactive protein were observed. Side effects included fever, rigors, and headache in the majority of patients. Hypotension was observed in three of five patients at the highest dose level (0.1 μg/kg) and was dose-limiting. Fewer days of neutropenia were noted after 5-FU plus IL-1β than after 5-FU alone; however, this difference did not reach statistical significance. These data show that IL-1β has stimulatory effects in human hematopoiesis.
Keywords: adult; clinical article; controlled study; aged; neutropenia; fluorouracil; bone marrow; colonic neoplasms; digestive system cancer; fever; hypotension; rigor; drug therapy, combination; recombinant proteins; hematopoiesis; blood glucose; headache; leukocyte count; hydrocortisone; rectal neoplasms; intravenous drug administration; platelet count; neoplasms, unknown primary; interleukin-1; middle age; drug evaluation; human; male; female; priority journal; article; support, non-u.s. gov't; support, u.s. gov't, p.h.s.; recombinant interleukin 1beta
Journal Title: Blood
Volume: 78
Issue: 6
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 1991-09-15
Start Page: 1420
End Page: 1427
Language: English
PUBMED: 1884014
PROVIDER: scopus
DOI: 10.1182/blood.V78.6.1420.1420
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David P Kelsen
    537 Kelsen
  2. Malcolm A S Moore
    549 Moore
  3. Nancy Kemeny
    543 Kemeny
  4. Janice Gabrilove
    122 Gabrilove
  5. John Crown
    47 Crown
  6. José F. Botet
    60 Botet
  7. George Y. Wong
    89 Wong